Gravitate Health FHIR Implementation Guide, published by Gravitate Health Project. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/joofio/test-epi-composition/ and changes regularly. See the Directory of published versions
Full name:
Authorised dose form:
Legal status of supply:
Domain:
Resource status:
Product classification:
Document Details
Generated Narrative: Bundle TEST PURPOSES ONLY - posaconazole
Language: en
Profile: Bundle - ePI
Final Document at 2022-02-16 13:28:17+0000 by Organization ACME industry for Bundle: identifier = http://ema.europa.eu/identifier#None; type = document; timestamp = 2023-06-27 10:09:22+0000
Document Subject
Generated Narrative: MedicinalProductDefinition mp2e5fc8a9ad9427a49a8dfdfc9d19d676
identifier: http://ema.europa.eu/identifier
/EU/1/19/1380/001
type: Medicinal Product
domain: Human use
status: active
legalStatusOfSupply: Medicinal product subject to medical prescription
name
productName: Posaconazole AHCL 40 mg/mL oral suspension
type: Full name
part
part: nan
type: Invented name part
part
part: nan
type: Scientific name part
part
part: nan
type: Strength part
part
part: nan
type: Pharmaceutical dose form part
Usages
Country Jurisdiction Language EU EU en
Document Content
Generated Narrative: Composition composition-en-2e5fc8a9ad9427a49a8dfdfc9d19d676
Language: en
Profile: Composition (ePI)
identifier: http://ema.europa.eu/identifier
/EU/1/19/1380/001
status: Final
type: Package Leaflet
category: Raw
date: 2022-02-16 13:28:17+0000
author: Organization ACME industry
title: TEST PURPOSES ONLY - posaconazole
Mode | Time |
Official | 2022-02-16 13:28:17+0000 |
What is in this leaflet
Posaconazole AHCL contains a medicine called posaconazole. This belongs to a group of medicines called antifungals . It is used to prevent and treat many different fungal infections.
This medicine works by killing or stopping the growth of some types of fungi that can cause infections.
Posaconazole AHCL can be used in adults to treat the following types of fungal infections when other antifungal medicines have not worked or you have had to stop taking them:
This medicine can also be used to prevent fungal infections in adults who are at high risk of getting a fungal infection, such as:
Do not take Posaconazole AHCL
Do not take Posaconazole AHCL if any of the above apply to you. If you are not sure, talk to your doctor or pharmacist before taking Posaconazole AHCL.
See Other medicines and Posaconazole AHCL below for more information including information on other medicines which may interact with Posaconazole AHCL.
Warnings and precautions Talk to your doctor or pharmacist before taking Posaconazole AHCL
If any of the above apply to you (or you are not sure), talk to your doctor, pharmacist or nurse before taking Posaconazole AHCL.
If you develop severe diarrhoea or vomiting (being sick) while taking Posaconazole AHCL, talk to your doctor, pharmacist or nurse straight away, as this may stop it from working properly. See Section 4 for more information
Children Posaconazole AHCL should not be used in children and adolescents (17 years of age and younger).
Other medicines and Posaconazole AHCL Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines.
Do not take Posaconazole AHCL if you are taking any of the following:
Posaconazole AHCL can increase the amount of these medicines in the blood which may lead to very serious changes to your heart rhythm:
Do not take Posaconazole AHCL if any of the above apply to you. If you are not sure, talk to your doctor or pharmacist before taking this medicine.
Other medicines Look at the list of medicines given above that must not be taken while you are taking Posaconazole AHCL. In addition to the medicines named above there are other medicines that carry a risk of rhythm problems that may be greater when they are taken with Posaconazole AHCL. Please make sure you tell your doctor about all the medicines you are taking (prescribed or non-prescribed).
Certain medicines may increase the risk of side effects of Posaconazole AHCL by increasing the amount of Posaconazole AHCL in the blood.
The following medicines may decrease the effectiveness of Posaconazole AHCL by decreasing the amount of Posaconazole AHCL in the blood:
Posaconazole AHCL may possibly increase the risk of side effects of some other medicines by increasing the amount of these medicines in the blood. These medicines include:
If any of the above apply to you (or you are not sure), talk to your doctor or pharmacist before taking Posaconazole AHCL.
Posaconazole AHCL with food and drink To improve absorption of posaconazole, whenever possible it should be taken during or immediately after food or a nutritional drink (see section 3 How to take Posaconazole AHCL ). There is no information on the effect of alcohol on posaconazole."
Pregnancy and breast-feeding Tell your doctor if you are or think you are pregnant before you start to take Posaconazole AHCL. Do not take Posaconazole AHCL if you are pregnant unless you are told to by your doctor.
If you are a woman who could become pregnant you should use effective contraception while you are taking this medicine. If you become pregnant while you are taking Posaconazole AHCL, contact your doctor straight away.
Do not breast-feed while taking Posaconazole AHCL. This is because small amounts may pass into breast milk.
Driving and using machines You may feel dizzy, sleepy, or have blurred vision while taking Posaconazole AHCL, which may affect your ability to drive or use tools or machines. If this happens, do not drive or use any tools or machines and contact your doctor.
Posaconazole AHCL contains glucose Posaconazole AHCL contains approximately 1.75 g of glucose per 5 mL of suspension. If you have been told by your doctor that you have an intolerance to some sugars, contact your doctor before taking this medicine.
This medicine contains less than 1 mmol sodium (23 mg) per 5 mL of suspension, that is to say essentially sodium-free .
Do not switch between taking Posaconazole tablets and posaconazole oral suspension without talking to your doctor or pharmacist because it may result in a lack of efficacy or an increased risk of adverse reactions.
Always take this medicine exactly as your doctor or pharmacist has told you. Check with your doctor or pharmacist if you are not sure. Your doctor will monitor your response and condition to determine how long Posaconazole AHCL needs to be given and whether any change is needed to your daily dose.
The table below shows the recommended dose and length of treatment which depend on the type of infection that you have and may be individually adapted for you by your doctor. Do not adapt your dose yourself before consulting your doctor or change your treatment regime.
Whenever possible you should take posaconazole during or immediately after food or a nutritional drink.
Indication Recommended dose and length of treatment Treatment of refractory Fungal Infections (Invasive aspergillosis, Fusariosis, Chromoblastomycosis/Mycetoma, Coccidioidomycosis) The recommended dose is 200 mg (one 5 mL spoonful) taken four times daily. Alternatively, if recommended by your doctor, you may take 400 mg (two 5 mL spoonfuls) twice a day provided that you are able to take both doses during or after food or a nutritional drink. First time treatment of Thrush On the first day of treatment take 200 mg (one 5 mL spoonful) once. After the first day, take 100 mg (2.5 mL) once a day. Prevention of serious Fungal Infections Take 200 mg (one 5 mL spoonful) three times a day.
If you take more Posaconazole AHCL than you should If you are concerned that you may have taken too much, contact your doctor or healthcare professional immediately.
If you forget to take Posaconazole AHCL If you have missed a dose, take it as soon as you remember and then carry on as before. However, if it is almost time for your next dose, take your dose when it is due. Do not take a double dose to make up for a forgotten dose.
If you have any further questions on the use of this medicine, ask your doctor, pharmacist or nurse.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
Serious side effects Tell your doctor, pharmacist or nurse straight away if you notice any of the following serious side effects you may need urgent medical treatment:
Other side effects Tell your doctor, pharmacist or nurse if you notice any of the following side effects:
Common: the following may affect up to 1 in 10 people
Uncommon: the following may affect up to 1 in 100 people
Rare: the following may affect up to 1 in 1,000 people
Not known: frequency cannot be estimated from the available data
Tell your doctor, pharmacist or nurse if you notice any of the side effects listed above.
Reporting of side effects If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the national reporting system listed in Appendix V. By reporting side effects you can help provide more information on the safety of this medicine.
What Posaconazole AHCL contains The active substance is posaconazole. Each millilitre of oral suspension contains 40 milligrams of posaconazole.
The other ingredients in the suspension are macrogolglycerol hydroxystearate, sodium citrate dihydrate, citric acid monohydrate, simeticone emulsion (containing polydimethylsiloxane, polyethylene glycol sorbitan tristearate, methylcellulose, silica gel, polyethylene glycol stearate, sorbic acid (E200), benzoic acid (E210) and sulfuric acid (E513)), xanthan gum (E415), sodium benzoate (E211), liquid glucose, glycerol (E422), titanium dioxide (E171), strawberry flavour (containing propylene glycol) and purified water.
What Posaconazole AHCL looks like and contents of the pack Posaconazole AHCL is a white to off-white free flowing suspension, packaged in amber glass bottle. A measuring spoon is provided with each bottle for measuring 2.5 and 5 mL doses of the oral suspension.
Marketing Authorisation Holder Accord Healthcare S.L.U. World Trade Center, Moll de Barcelona s/n,
Edifici Est, 6a planta, Barcelona, 08039 Barcelona, Spain
Manufacturer Laboratori Fundacio Dau C/ C, 12-14 Pol. Ind. Zona Franca, 08040 Barcelona, Spain
Pharmadox Healthcare Ltd. KW20A Kordin Industrial Park Paola, PLA 3Malta
Accord Healthcare Polska Sp. z o.o. ul. Lutomierska 50,
95-200 Pabianice
Poland
This leaflet was last revised in {MM/YYYY}
Other sources of information
Detailed information on this medicine is available on the European Medicines Agency web site:
Entry 1 - fullUrl = Composition/composition-en-2e5fc8a9ad9427a49a8dfdfc9d19d676
Resource Composition:
Generated Narrative: Composition composition-en-2e5fc8a9ad9427a49a8dfdfc9d19d676
Language: en
Profile: Composition (ePI)
identifier:
http://ema.europa.eu/identifier
/EU/1/19/1380/001status: Final
type: Package Leaflet
category: Raw
date: 2022-02-16 13:28:17+0000
author: Organization ACME industry
title: TEST PURPOSES ONLY - posaconazole
Attesters
Mode Time Official 2022-02-16 13:28:17+0000
Entry 2 - fullUrl = MedicinalProductDefinition/mp2e5fc8a9ad9427a49a8dfdfc9d19d676
Resource MedicinalProductDefinition:
Generated Narrative: MedicinalProductDefinition mp2e5fc8a9ad9427a49a8dfdfc9d19d676
identifier:
http://ema.europa.eu/identifier
/EU/1/19/1380/001type: Medicinal Product
domain: Human use
status: active
legalStatusOfSupply: Medicinal product subject to medical prescription
name
productName: Posaconazole AHCL 40 mg/mL oral suspension
type: Full name
part
part: nan
type: Invented name part
part
part: nan
type: Scientific name part
part
part: nan
type: Strength part
part
part: nan
type: Pharmaceutical dose form part
Usages
Country Jurisdiction Language EU EU en